July 9, 2021
The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”
June 3, 2021
Alzheimer’s and dementia already afflict too many people, yet their prevalence is expected to more than double in the coming…
May 28, 2021
The Institute for Clinical and Economic Review claims that the first disease-modifying treatment for Alzheimer’s disease isn’t worth its cost.
May 11, 2021
The heartbreaking headline said it all: a new CAR-T personalized cancer treatment was found “effective, but too costly” by the economists at the Institute for Clinical and Economic Research.
April 30, 2021
An efficacious treatment that reduces the symptoms and risk factors associated with obstructive hypertrophic cardiomyopathy delivers great value to patients.…
April 30, 2021
Very few of the more than 5 million Americans, or their caregivers, who live with Alzheimer’s have ever heard of the Institute for Clinical and Economic Review.
March 3, 2021
Preventing a serious cardiac event is a top priority for my patients, but the Institute for Clinical and Economic Review is about to make prevention a whole lot harder.
December 15, 2020
When you or someone you love has a cardiovascular event, life gets real – fast.
February 25, 2020
What is the value of advanced medicine for a patient living with migraine? It’s not a simple question.
December 19, 2019
Before closing the door on 2019, IfPA looks back at the trends that impacted patient access this year.